Qualified Health Claims Research Supports Moratorium On Claims – CSPI

"FDA should rescind its approval of all qualified health claims and impose a moratorium on the approval of additional qualified claims" that do not meet significant scientific agreement standards, the Center for Science in the Public Interest argued following a presentation of consumer research on health claims